These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7483258)

  • 21. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.
    Hajeer AH; Snowden N; Wilson P; Drover S; Ollier WE
    Immunology; 1993 Dec; 80(4):593-7. PubMed ID: 8307609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.
    Oda T; Imai S; Chiba S; Takada K
    Virology; 2000 Oct; 276(1):52-8. PubMed ID: 11021994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.
    Levine J; Pflugfelder SC; Yen M; Crouse CA; Atherton SS
    Reg Immunol; 1990-1991; 3(4):164-70. PubMed ID: 1966579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of heavy chain and beta2-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication.
    Guerreiro-Cacais AO; Uzunel M; Levitskaya J; Levitsky V
    J Virol; 2007 Feb; 81(3):1390-400. PubMed ID: 17108039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.
    Ahearn JM; Hayward SD; Hickey JC; Fearon DT
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9307-11. PubMed ID: 2848261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human epithelial cell expression of an Epstein-Barr virus receptor.
    Sixbey JW; Davis DS; Young LS; Hutt-Fletcher L; Tedder TF; Rickinson AB
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():805-11. PubMed ID: 3029307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms in Epstein-Barr virus infection and replication].
    Sairenji T; Mori T; Ohashi M; Horie K; Touge C
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():543-6. PubMed ID: 16615531
    [No Abstract]   [Full Text] [Related]  

  • 33. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL.
    Paterson RL; Kelleher C; Amankonah TD; Streib JE; Xu JW; Jones JF; Gelfand EW
    Blood; 1995 Jan; 85(2):456-64. PubMed ID: 7811999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
    Lindsey JW; Khan U; Ansari W; Powell T; Wang YH; Guirguis MS
    J Neuroimmunol; 2013 Jan; 254(1-2):146-53. PubMed ID: 23026221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus in synergy with tumor-promoter-induced malignant transformation of immortalized human epithelial cells.
    Li BM; Ji ZW; Liu ZS; Zeng Y
    J Cancer Res Clin Oncol; 1997; 123(8):441-6. PubMed ID: 9292707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.
    Fares S; Spiess K; Olesen ETB; Zuo J; Jackson S; Kledal TN; Wills MR; Rosenkilde MM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody.
    Simmons JG; Hutt-Fletcher LM; Fowler E; Feighny RJ
    J Immunol; 1983 Mar; 130(3):1303-8. PubMed ID: 6337215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.
    Haan KM; Kwok WW; Longnecker R; Speck P
    J Virol; 2000 Mar; 74(5):2451-4. PubMed ID: 10666279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.
    Nemerow GR; Mullen JJ; Dickson PW; Cooper NR
    J Virol; 1990 Mar; 64(3):1348-52. PubMed ID: 2154612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.
    Möhl BS; Chen J; Sathiyamoorthy K; Jardetzky TS; Longnecker R
    Mol Cells; 2016 Apr; 39(4):286-91. PubMed ID: 27094060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.